glp 1 receptor agonists and kidney protection Role of GLP-1 & SGLT-2 Inhibitors in Care Glucagon-like peptide 1(GLP-1) receptor agonists

Lancet (London, England) 365(9457):417430

Ngi b hen suyn Ngi b lot nim mc d dy C tin s ung th da D ng vi cc thnh phn ca sn phm Ph n mang thai v cho con b CCH UNG, S DNG GLUTATHIONE HIU QU HP TH NHANH Liu lng ung glutathione trng da Ty vo mc ch s dng glutathione v cng thc ca sn phm

10.1002/chem.201704561 19 BrandesR

WuWLiRLiXHeJJiangSLiuSet al

The systemic response initiates with a rapid increase of pro-inflammatory components (IL-6, IL-8), which in turn generates an anti-inflammatory feedback by increasing the release of interleukin (IL)-10 and interleukin (IL)-1 receptor antagonist [70]

2022;145(18):e895-1032